Atrium Therapeutics, Inc. - RNA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | See Remarks | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | See Remarks | A | A | 30,000.0 | 0.0 | 0.0 | 35,460.0 | View | |
| Apr 22, 2026 | Chief Medical Officer | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | Chief Medical Officer | A | A | 30,000.0 | 0.0 | 0.0 | 73,097.0 | View | |
| Apr 22, 2026 | Chief Financial Officer | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | Chief Financial Officer | A | A | 30,000.0 | 0.0 | 0.0 | 43,601.0 | View | |
| Apr 22, 2026 | See Remarks | A | A | 205,000.0 | 0.0 | 0.0 | 205,000.0 | View | |
| Apr 22, 2026 | See Remarks | A | A | 102,500.0 | 0.0 | 0.0 | 131,361.0 | View | |
| Apr 22, 2026 | Chief Strategy Officer | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | Chief Strategy Officer | A | A | 30,000.0 | 0.0 | 0.0 | 46,660.0 | View | |
| Apr 22, 2026 | Chief Scientific Officer | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | Chief Scientific Officer | A | A | 30,000.0 | 0.0 | 0.0 | 52,657.0 | View | |
| Mar 02, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 02, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 02, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 02, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 02, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View |